Experimental study finds remote ischemic conditioning may protect the heart during anthracycline treatment
May 20, 2026
An experimental study found remote ischemic conditioning protected the heart during anthracycline treatment in tumor-bearing mice without reducing antitumor efficacy. The work supports the ongoing RESILIENCE clinical trial in cancer patients.